WHO

WHO reports increasing rates of HIV drug resistance to dolutegravir

March 8, 2024 - Earlier this week, the World Health Organization (WHO) issued a news release stating that there are increased trends in human immunodeficiency virus (HIV) drug resistance to dolutegravir. Despite this alarming news, the report does note relatively high rates of viral suppression among patients using this therapy. According to the surveys,...

Read More


More Articles

Understanding the Pharmacotherapy of Hypertensive Disorders

by Veronica Salib

Hypertension is defined as a chronic condition characterized by high blood pressure. In an earlier publication, LifeSciencesIntelligence explored the different kinds of hypertensive disorders, their causes, and management. In this article,...

Navigating the Complex Terrain of Influenza Vaccine Strain Selection

by Alivia Kaylor

In the battle against influenza, the annual selection of vaccine strains is a crucial step in ensuring the effectiveness of flu vaccines. The process involves an intricate dance of global surveillance, scientific analysis, and regulatory...

Biden Leverages DPA to Strengthen Pharmaceutical Supply Chain

by Veronica Salib

On Monday, November 27, 2023, the White House released a fact sheet from the Biden administration outlining plans to strengthen domestic supply chains, reduce consumer costs, and secure key supply...

WHO Urged Actions to Stop Antimicrobial Resistance

by Veronica Salib

The World Health Organization (WHO) recognizes World Antimicrobial Resistance Week from November 18, 2023, to November 24, 2023. Throughout this week, the organization highlights data on antimicrobial...

Evaluating the Breast Cancer Therapeutics Market

by Veronica Salib

As breast cancer awareness month continues, gathering a comprehensive understanding of the breast cancer therapeutics market is critical, including current trends and market players, gaps, and predictions for the coming year. Understanding...

10 Things to Know About the Updated 2023 COVID-19 Vaccines

by Alivia Kaylor

With the onset of the fall season, many Americans are grappling with numerous questions about COVID-19 booster shots, the flu vaccine, and respiratory syncytial virus (RSV) protection. This year's vaccine rollout has encountered...

WHO Updates HPV Vaccine Guidelines: Shift Toward Single Dose Series

by Veronica Salib

Following the WHO Strategic Advisory Group of Experts on Immunization (SAGE) earlier this year, the organization released an article updating its human papillomavirus (HPV) vaccine guidelines after...

WHO Updates COVID-19 Vaccination Guidance After March SAGE Meeting

by Veronica Salib

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) announced the results of its March meeting, updating its COVID-19 vaccination guidance. According to the news release, the...

Scientists Explore HIV Treatments, Drugs, Vaccines, and Gene Therapy

by Veronica Salib

Human immunodeficiency virus (HIV), a viral infection that attacks and weakens the immune system, impacts 38.4 million people worldwide. According to the WHO, in 2021, 650,000 people globally died of an HIV-related illness. Despite high...

Considerations in Pediatric Clinical Trials, Ensuring Patient Safety

by Veronica Salib

The clinical trial landscape — globally and in the United States — is one of many complexities, difficulties, implications, and guidelines. Clinical trials can provide critical information on treating chronic and acute...

Initiating Dementia Treatment, Pharmacological Interventions

by Veronica Salib

The WHO notes that approximately 55 million people in the world have dementia. Considering the rate of aging and the complications that coincide with aging, Alzheimer's Disease International anticipates that the number of people with...

WHO Recommends Use of Monoclonal Antibodies in Ebola Treatment

by Veronica Salib

Ebola virus disease (EVD) is a potentially fatal disease caused by infection with ebolavirus. This WHO statement regards EVD caused by the Zaire ebolavirus. Following a review of many randomized...

HHS Statement on FDA Approval of Bavarian Nordic Monkeypox Vaccine

by Veronica Salib

On Saturday, July 23, 2022, the director-general of the WHO declared monkeypox a public health crisis. Public health organizations have encouraged vaccination for at-risk populations to minimize the...

Global Vaccination Coverage Dropped 5% in 2021

by Veronica Salib

In a recent statement, the WHO analyzed global vaccination coverage and found that in 2021 immunization rates dropped by 5%. Furthermore, the WHO outlined the 2030 immunization agenda and international...

Epilepsy Drug Prices Have Increased by 277% in the Past Decade

by Veronica Salib

In one decade, brand-name epilepsy drug prices have increased by 277%, according to a recent press release by the American Academy of Neurology. This review looked at data from Medicare patients...

US FDA Approves GSK’s Priorix Measles, Mumps, and Rubella Vaccine

by Alivia Kaylor

Earlier this month, the FDA approved GSK’s Priorix measles, mumps, and rubella (MMR) vaccine in the United States for individuals 12 months and older. MMR vaccines are recommended in a...

Recent Articles